163 related articles for article (PubMed ID: 36526851)
1. A synergistic partnership between IL-33/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis.
Kwon JW; Seok SH; Kim S; An HW; Choudhury AD; Woo SH; Oh JS; Kim JK; Voon DC; Kim DY; Park JW
Oncogene; 2023 Feb; 42(7):501-515. PubMed ID: 36526851
[TBL] [Abstract][Full Text] [Related]
2. IL‑33/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway.
Huang N; Cui X; Li W; Zhang C; Liu L; Li J
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760194
[TBL] [Abstract][Full Text] [Related]
3. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation.
Lin L; Li Y; Liu M; Li Q; Liu Q; Li R
Aging (Albany NY); 2020 Jan; 12(2):1685-1703. PubMed ID: 32003751
[TBL] [Abstract][Full Text] [Related]
4. Stem Cells Antigen-1 Enriches for a Cancer Stem Cell-Like Subpopulation in Mouse Gastric Cancer.
Park JW; Park JM; Park DM; Kim DY; Kim HK
Stem Cells; 2016 May; 34(5):1177-87. PubMed ID: 26869189
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
6. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer.
Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P
Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767
[TBL] [Abstract][Full Text] [Related]
7. IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways.
Naef P; Radpour R; Jaeger-Ruckstuhl CA; Bodmer N; Baerlocher GM; Doehner H; Doehner K; Riether C; Ochsenbein AF
Sci Signal; 2023 Aug; 16(800):eadd7705. PubMed ID: 37643244
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-33 Predicts Poor Prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway.
Wu CW; Wu YG; Cheng C; Hong ZD; Shi ZM; Lin SQ; Li J; He XY; Zhu AY
Cell Physiol Biochem; 2018; 47(1):191-200. PubMed ID: 29763892
[TBL] [Abstract][Full Text] [Related]
9. Gastric cancer mesenchymal stem cells regulate PD-L1-CTCF enhancing cancer stem cell-like properties and tumorigenesis.
Sun L; Huang C; Zhu M; Guo S; Gao Q; Wang Q; Chen B; Li R; Zhao Y; Wang M; Chen Z; Shen B; Zhu W
Theranostics; 2020; 10(26):11950-11962. PubMed ID: 33204322
[No Abstract] [Full Text] [Related]
10. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance.
Wang T; Wu H; Liu S; Lei Z; Qin Z; Wen L; Liu K; Wang X; Guo Y; Liu Q; Liu L; Wang J; Lin L; Mao C; Zhu X; Xiao H; Bian X; Chen D; Xu C; Wang B
Cancer Lett; 2018 Aug; 430():11-24. PubMed ID: 29746925
[TBL] [Abstract][Full Text] [Related]
11. The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma.
Rasheed K; Moens U; Policastro B; Johnsen JI; Koljonen V; Sihto H; Lui WO; Sveinbjørnsson B
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409061
[TBL] [Abstract][Full Text] [Related]
12. Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis.
Chen L; Wang G; Qiao X; Wang X; Liu J; Niu X; Zhong M
Med Sci Monit; 2020 Jan; 26():e921863. PubMed ID: 31990904
[TBL] [Abstract][Full Text] [Related]
13. The IL-33/ST2 axis affects tumor growth by regulating mitophagy in macrophages and reprogramming their polarization.
Xu H; Li D; Ma J; Zhao Y; Xu L; Tian R; Liu Y; Sun L; Su J
Cancer Biol Med; 2021 Feb; 18(1):172-183. PubMed ID: 33628592
[TBL] [Abstract][Full Text] [Related]
14. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-33/ST2 Signaling Promotes Hepatocellular Carcinoma Cell Stemness Expansion Through Activating c-Jun N-terminal Kinase Pathway.
Zhao R; Yu Z; Li M; Zhou Y
Am J Med Sci; 2019 Oct; 358(4):279-288. PubMed ID: 31420092
[TBL] [Abstract][Full Text] [Related]
16. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
17. IL-33/ST2 axis promotes the inflammatory response of nasal mucosal epithelial cells through inducing the ERK1/2 pathway.
Li YQ; Zhong Y; Xiao XP; Li DD; Zhou Z; Tian YY
Innate Immun; 2020 Aug; 26(6):505-513. PubMed ID: 32456598
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of ST2 (IL-1R4) specific for IL-33 activity; no suppression by IL-1Ra though a common chain IL-1R3 (IL-1RAcP) shared with IL-1.
Jo S; Kim E; Kwak A; Lee J; Hong J; Lee J; Youn S; Bae S; Kim B; Ryoo S; Kang TB; Her E; Choi DK; Kim YS; Lee Y; Jhun H; Kim S
Cytokine; 2016 Jul; 83():33-40. PubMed ID: 27031441
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer.
Yong X; Tang B; Xiao YF; Xie R; Qin Y; Luo G; Hu CJ; Dong H; Yang SM
Cancer Lett; 2016 May; 374(2):292-303. PubMed ID: 26940070
[TBL] [Abstract][Full Text] [Related]
20. IL-17B/IL-17RB signaling cascade contributes to self-renewal and tumorigenesis of cancer stem cells by regulating Beclin-1 ubiquitination.
Bie Q; Song H; Chen X; Yang X; Shi S; Zhang L; Zhao R; Wei L; Zhang B; Xiong H; Zhang B
Oncogene; 2021 Mar; 40(12):2200-2216. PubMed ID: 33649532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
